CRBU
Caribou Biosciences, Inc.
A clinical-stage biotech building "off-the-shelf" CAR-T cell therapies that treat blood cancers using healthy donor cells instead of a patient's own, with two candidates in early trials. It was founded in Berkeley in 2011 by CRISPR pioneer and Nobel laureate Jennifer Doudna and her team, and the name "Caribou" nods to the CRISPR enzymes behind its work. Insiders even joke that its chRDNA editing technology sounds like "chardonnays," the wine.
CUSIP: 142038108HealthcareUS1 holder
Total Value
$1.15M
Total Shares
652.5K
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
